Dr. Theberge is a radiation oncologist at the CHU de Québec-Université Laval and a member of the Deschênes-Fabia breast disease center. She obtained her doctorate in medicine at Sherbrooke University and speciality diploma in radiation oncology at Laval University. She completed a fellowship in breast cancer at McMaster University in Ontario.
She is a researcher at the CHU de Québec research center and responsible for clinical research in breast cancer in radiation oncology at the CHU de Québec. She is a member of the executive committee for breast cancer research at the Canadian cancer trials group (CCTG).
Her main fields of interest are the improvement of radiotherapy techniques in breast cancer and the development of targeted treatments according to the biology of the disease with the aim of reducing side effects and improving the quality of life of patients. She is responsible of the quality assurance program for the randomized trial MA.39 evaluating regional irradiation for patients with breast cancer Luminal A, a North American CCTG trial.